▶ 調査レポート

婦人科用医療機器の世界市場:製品タイプ別(婦人科用内視鏡装置、流体管理装置、ハンドヘルド機器、子宮内膜アブレーション機器 、女性の不妊治療用機器、画像診断装置)、地域別分析

• 英文タイトル:Global Gynecological Devices Market - Segmented by Product, and Geography - Growth, Trends, and Forecast (2018 - 2023)

Mordor Intelligenceが調査・発行した産業分析レポートです。婦人科用医療機器の世界市場:製品タイプ別(婦人科用内視鏡装置、流体管理装置、ハンドヘルド機器、子宮内膜アブレーション機器 、女性の不妊治療用機器、画像診断装置)、地域別分析 / Global Gynecological Devices Market - Segmented by Product, and Geography - Growth, Trends, and Forecast (2018 - 2023) / B-MOR-08218資料のイメージです。• レポートコード:B-MOR-08218
• 出版社/出版日:Mordor Intelligence / 2018年6月20日
• レポート形態:英文、PDF、108ページ
• 納品方法:Eメール(受注後2営業日)
• 産業分類:Healthcare
• 販売価格(消費税別)
  Single User(1名様用)¥450,500 (USD4,250)▷ お問い合わせ
  Team User(7名様用)¥477,000 (USD4,500)▷ お問い合わせ
  Corporate User¥927,500 (USD8,750)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本資料は、婦人科用医療機器の世界市場について調べ、婦人科用医療機器の世界規模、市場動向、市場環境、製品タイプ別(婦人科用内視鏡装置、流体管理装置、ハンドヘルド機器、子宮内膜アブレーション機器 、女性の不妊治療用機器、画像診断装置)分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。
・イントロダクション
・エグゼクティブサマリー
・婦人科用医療機器の世界市場インサイト
・婦人科用医療機器の世界市場環境
・婦人科用医療機器の世界市場動向
・婦人科用医療機器の世界市場規模
・婦人科用医療機器の世界市場規模:製品タイプ別(婦人科用内視鏡装置、流体管理装置、ハンドヘルド機器、子宮内膜アブレーション機器 、女性の不妊治療用機器、画像診断装置)
・婦人科用医療機器の世界市場:地域別市場規模・分析
・婦人科用医療機器の北米市場規模・予測
・婦人科用医療機器のアメリカ市場規模・予測
・婦人科用医療機器のヨーロッパ市場規模・予測
・婦人科用医療機器のアジア市場規模・予測
・婦人科用医療機器の日本市場規模・予測
・婦人科用医療機器の中国市場規模・予測
・婦人科用医療機器のインド市場規模・予測
・婦人科用医療機器の韓国市場規模・予測
・関連企業情報・競争状況

The global gynecological devices market is expected to register a growth rate of nearly 7.4% during the forecast period, 2018-2023. Gynecological devices refer to surgical and monitoring devices used for gynecological conditions and disorders, such as fluid management, endometrial ablation, female sterilization, and gynecological endoscopy.

Rising Gynecological Disorders and Associated Surgical Procedures to Propel the Gynecological Devices Market

Increase in gynecological disorders, such as ovarian cancer, cervical cancer, uterine cancer, polycystic ovarian syndrome (PCOS), and vaginal and vulvar cancer are driving the market for gynecological devices across the world. The American Cancer Society states that average age of endometrial cancer diagnosis in women is 60, whereas it isn’t common amongst women below the age of 45. In addition, WHO suggests a routine endometrial ablation procedure should be performed for women above the age of 35, in order to avoid the risks associated with endometrial cancer. Obesity, diabetes, and PCOS patients are more susceptible to endometrial cancer at the ages of 18 to 35 and require endometrial biopsy. This is in turn increasing the demand for gynecological devices globally.
Similarly the rise in other issues such as PCOS, ovarian cancer, vaginal cancer, and uterine cancer lead to the growing adoption of surgical procedures, such as endoscopy, laparoscopy, and female sterilization. Hence, the rise in gynecological cancers and increasing surgical procedures associated with them are expected to drive the overall gynecological disorders market over the forecast period.

Stringent Regulatory Guidelines to Limit Growth of the Gynecological Devices Market
The stringent regulatory guidelines associated with the safety, efficacy, and accuracy of the gynecological devices are expected to restrain the market growth. The gynecological devices are covered under Class II medical devices and have to go through tedious approval procedures. The FDA not only regulates the design, preclinical results but also monitors the accuracy, safety and efficacy of the gynecological devices post approval. This is in turn expected to hamper the adoption of gynecological devices and increase complications in their approval procedures. Hence, impeding the market for gynecological devices over the forecast period.

Asia-Pacific to Witness the Lucrative Growth in the Global Gynecological Devices Market
The presence of large prospect patient pool, in countries like India and China, drives the market for gynecological devices in the Asia-Pacific region. Hence, the region is expected to exhibit lucrative growth rate over the forecast period.
The large population base of these countries have encouraged government initiatives for birth control. This has led to an increase in the awareness concerning contraception that has in turn led to the adoption of female sterilization devices. One such example is the birth control measures in China, which emphasized the one child policy.
In addition, the higher prevalence of sexually transmitted diseases amongst the youth in countries, such as Vietnam, Japan, and Bangladesh due to lack of easy access to the contraceptive products and the lack of awareness are expected to create new growth opportunities for the market players. Hence, owing to the aforementioned factors, the Asia-Pacific gynecological devices market is expected to exhibit fastest growth rate over the forecast period.

Key Developments in the Gynecological Devices Market

• April, 2017 – Cooper Surgical announced acquisition of LifeGlobal Group, in order to expand its fertility solutions portfolio.
• April, 2018 – Olympus Corporation and InterSystems collaboratively declared the introduction of its new endoscopy integration capabilities.

Major Players – BOSTON SCIENTIFIC CORPORATION, COOPER SURGICAL, ETHICON INC., HOLOGIC, INC., KARL STORZGMBH & CO. KG, MEDTRONIC PLC, OLYMPUS CORPORATION, AND RICHARD WOLF GMBH, amongst others.

Reasons to Purchase the Report

• The current and future of gynecological devices market outlook in the developed and emerging markets
• Analysis of various perspectives of the market with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3-month analyst support, along with the Market Estimate sheet (in excel)

Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs

レポート目次

1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter’s Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Products and Services
5.2.5 Competitive Rivalry within the Industry
5.3 Pipeline Analysis
5.4 Regulatory Scenario
6. Market Dynamics
6.1 Market Drivers
6.1.1 Increasing Prevalence of Gynecological Disorders
6.1.2 Growing Awareness regarding Gynecological Check-ups
6.1.3 Rise in Surgical Procedures
6.2 Market Restraints
6.2.1 Rapidly Developing Alternative Therapies
6.2.2 Stringent Regulatory Guidelines
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Product Type
7.1.1 Gynecological Endoscopy Devices
7.1.1.1 Hysteroscope
7.1.1.2 Resectoscope
7.1.1.3 Colposcope
7.1.1.4 Endoscopic Imaging Systems
7.1.1.5 Laparoscope
7.1.2 Fluid Management Systems
7.1.3 Hand Instruments
7.1.4 Endrometrial Ablation Devices
7.1.4.1 Baloon Ablation Devices
7.1.4.2 Hydrothermal Ablation Devices
7.1.4.3 Radiofrequency Ablation Devices
7.1.4.4 Others
7.1.5 Female Sterilization Devices
7.1.5.1 Temporary Birth Control
7.1.5.2 Permanent Birth Control
7.1.6 Diagnostic Imaging Systems
7.2 By Geography
7.2.1 North America
7.2.1.1 United States
7.2.1.2 Canada
7.2.1.3 Mexico
7.2.2 Europe
7.2.2.1 France
7.2.2.2 Germany
7.2.2.3 United Kingdom
7.2.2.4 Italy
7.2.2.5 Spain
7.2.2.6 Rest of Europe
7.2.3 Asia-Pacific
7.2.3.1 China
7.2.3.2 Japan
7.2.3.3 India
7.2.3.4 Australia
7.2.3.5 South Korea
7.2.3.6 Rest of Asia-Pacific
7.2.4 Middle East & Africa
7.2.4.1 GCC
7.2.4.2 South Africa
7.2.4.3 Rest of Middle East & Africa
7.2.5 South America
7.2.5.1 Brazil
7.2.5.2 Argentina
7.2.5.3 Rest of South America
8. Competitive Landscape
8.1 Merger & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 Boston Scientific Corporation
9.2 Cooper Surgical
9.3 Ethicon Inc.
9.4 Hologic Inc.
9.5 Karl StorzGmbH & Co. KG
9.6 Medtronic PLC
9.7 Olympus Corporation
9.8 Richard Wolf GmbH
9.9 Stryker
*List Not Exhaustive
10. Future of the Market